Abstract. Angiotensin II (AngII) regulates renal proximal transport in a biphasic way. It has been recently shown that the basolateral type 1A receptor (AT 1A ) mediates the biphasic regulation of Na ϩ -HCO 3 Ϫ cotransporter (NBC) by AngII. However, the receptor subtype(s) responsible for the luminal AngII actions remained to be established. To clarify this issue, the luminal AngII effects in isolated proximal tubules from wild-type (WT) and AT 1A -deficient mice (AT 1A KO) were compared. In WT, the rate of bicarbonate absorption (JHCO ] i in AT 1A KO. On the other hand, the addition of arachidonic acid similarly inhibited JHCO 3 Ϫ in WT and AT 1A KO. Furthermore, the acute activation of protein kinase C by phorbol 12-myristate 13-acetate similarly stimulated JHCO 3 Ϫ in WT and AT1A KO, indicating that the inhibitory and stimulatory pathways necessary for the AngII actions were preserved in AT 1A KO. These results indicate that the luminal AT 1A mediates the biphasic regulation of bicarbonate absorption by luminal AngII, while no evidence was obtained for a role of AT 2 .
Abstract. Angiotensin II (AngII) regulates renal proximal transport in a biphasic way. It has been recently shown that the basolateral type 1A receptor (AT 1A ) mediates the biphasic regulation of Na ϩ -HCO 3 Ϫ cotransporter (NBC) by AngII. However, the receptor subtype(s) responsible for the luminal AngII actions remained to be established. To clarify this issue, the luminal AngII effects in isolated proximal tubules from wild-type (WT) and AT 1A -deficient mice (AT 1A KO) were compared. In WT, the rate of bicarbonate absorption (JHCO 3 Ϫ ), analyzed with a stop-flow microspectrofluorometric method, was stimulated by 10 Ϫ10 mol/L luminal AngII but was inhibited by 10 Ϫ6 mol/L luminal AngII. Both stimulatory and inhibitory effects of AngII were completely blocked by valsartan (AT 1 KO . On the other hand, the addition of arachidonic acid similarly inhibited JHCO 3 Ϫ in WT and AT 1A KO. Furthermore, the acute activation of protein kinase C by phorbol 12-myristate 13-acetate similarly stimulated JHCO 3 Ϫ in WT and AT1A KO, indicating that the inhibitory and stimulatory pathways necessary for the AngII actions were preserved in AT 1A KO. These results indicate that the luminal AT 1A mediates the biphasic regulation of bicarbonate absorption by luminal AngII, while no evidence was obtained for a role of AT 2 .
Angiotensin II (AngII) receptors are divided into two distinct receptor subtypes, type 1 (AT 1 ) and type 2 (AT 2 ) receptors, and AT 1 receptors are further divided into AT 1A and AT 1B in rodents (1, 2) . Most of the physiologic effects of AngII are thought to be mediated by AT 1 , while the role of AT 2 remains unclear (1) (2) (3) . In addition to the effects on renal hemodynamics, AngII has direct effects on renal tubular functions. In particular, AngII acts on sodium and bicarbonate reabsorption from proximal tubules, and this process is thought to have significant impact on body fluid and sodium homeostasis (4 -7). Interestingly, AngII is known to regulate proximal transport in a biphasic way: stimulation by low (picomolar to nanomolar) concentrations of AII, and inhibition by high (nanomolar to micromolar) concentrations of AII (4, 5) . Previous studies have consistently shown that AT 1 mediates the stimulatory effect of AngII. However, conflicting results have been reported regarding the receptor subtype mediating the inhibitory effect of AngII. Thus, several studies supported a view that AT 1 mediates both stimulatory and inhibitory effects of AngII (8,9), whereas Haithcock et al. (10) presented the evidence that AT 2 mediates the inhibitory effect of AngII. Methodological differences may not fully account for these conflicting results, and the receptor subtype responsible for the inhibitory effect of AngII remained to be definitely determined. To clarify this issue, we have recently compared the effects of AngII on Na ϩ -HCO 3 Ϫ cotransporter (NBC) activity in isolated proximal tubules from wild-type (WT) and AT 1A -deficient mice (AT 1A KO). The results clearly showed that the basolateral AT 1A mediates both stimulation and inhibition of NBC by AngII (11). It could be still possible, however, that the apical AT 2 may mediate inhibition by AngII, because the study by Haithcock et al. (10) was conducted on cultured proximal tubular cells that might express the apical AT 2 , whereas our study was restricted on the basolateral receptors (11) . Previous studies have indeed shown that luminal AngII has also biphasic effects on proximal transport (12, 13) . In addition, a recent finding of remarkably high (nanomolar) proximal intratubular concentrations of AngII suggests an important role of luminal AII actions (13) . The purpose of the present study is therefore to compare the roles of luminal AT 1A and AT 2 in mediating the stimulatory and inhibitory effects of AngII using a combination of gene-targeted mice and specific receptor antagonists. To accomplish this task, we compared the effects of luminal AngII on the rate of bicarbonate absorption (JHCO 3 Ϫ ) in isolated proximal tubules from WT and AT 1A KO. This study was facilitated by a convenient microspectrofluorometric method, which we have recently developed for the determination of JHCO 3 Ϫ in isolated rabbit proximal tubules (14, 15) .
Materials and Methods

Animals
Male AT 1A KO mice (16) and WT mice (Discovery Research Laboratory, Tanabe Seiyaku), 5-to 8-wk-old, from the same genetic background were used in the present study. They were provided with standard food and water ad libitum. All animal procedures were in accordance with local institutional guidelines.
Microperfusion Technique
Mice were anesthetized with pentobarbital sodium, and the thin sections from the left kidney were obtained and stored in ice-cold, gas-equilibrated (5% CO 2 
2Ϫ , and 5.5 mmol/L D-glucose. Proximal tubules (S2 segment) were microdissected without collagenase treatment and then microperfused according to the method described by Burg et al. (17) with a modified version of the perfusion and sampling capillary system (14, 15) . The tubular lumen was perfused with the same gasequilibrated Ringer solution; however, D-glucose was omitted and 20 mmol/L NaCl was replaced by 40 mmol/L raffinose. We have previously shown that tissue culture media such as Dulbecco modified Eagle medium (DMEM) are essential to maintain a better functional state of isolated proximal tubules (18 -20) . In pilot experiments, we indeed confirmed that JHCO 3 Ϫ in isolated mouse proximal tubules was kept at high rates for more than 60 min in DMEM solution, but it deteriorated within 60 min in Ringer solution. In the present study, DMEM was therefore used as the bath perfusate. The experimental chamber was continuously perfused at a rate of approximately 10 ml/min with prewarmed (38°C) and gas-equilibrated (5% CO 2 /95% O 2 ) DMEM solution for 30 min, and the JHCO 3 Ϫ measurements were started.
Determination of JHCO 3
Ϫ
We used the recently described stop-flow microperfusion technique (14, 15) . In brief, isolated tubules were mounted on the stage of an inverted epifluorescence microscopy (IMT-2, Olympus). After background fluorescence was measured, a pH-sensitive fluorescence dye 2',7'-bis(carboxyethyl)-5 (6)-carboxyfluorescein (BCECF) was added to the luminal perfusate. Luminal pH (pH L ) was monitored by a microspectrofluorometer system (OSP-10, Olympus), which alternately illuminates the preparation with light of 440 and 490 nm and measures emission at the 530 nm wavelength. To obtain a calibration curve, lumen was perfused at high rates (Ͼ80 nl/min) with NaCl solutions buffered to pH 6.5 to 7.5 with 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid. To determine JHCO 3 Ϫ , the rapid (approximately 80 nl/min) luminal perfusion was abruptly stopped by suddenly reducing the perfusion pressure from approximately 18 to 0 cmH 2 O. After stop-flow, pH L fell from 7.4 to values near 6.8 within 30 s, where it remained virtually constant. This decrease in pH L reflects the gradual absorption of HCO 3 Ϫ and the attainment of a steady-state zero net volume flux that develops because of the presence of poorly absorbable raffinose in the luminal perfusate as described (14, 15) . The decay in luminal HCO 3 Ϫ concentration ([HCO 3 Ϫ ] L ) was calculated from the changes in pH L , and JHCO 3 Ϫ was calculated from the following equation: Ϫ ] L decline. During rapid luminal perfusion, the perfusion pressure will act to dilate the tubular lumen because the tubule itself as well as the collection pipette offers some resistance to flow. When the perfusion pressure is suddenly reduced to zero upon stop-flow, the tubular lumen tends to partially collapse. The correction for this volume loss into the pipettes was achieved by using the decaying 440 nm (pH-insensitive) fluorescence signals as a marker of the residual luminal volume. The validity of this correction strategy was confirmed by comparison with microphotographic and video measurements as described previously (14) .
Measurements of Cell Ca 2ϩ Concentrations ([Ca 2ϩ
] i ) [Ca 2ϩ ] i was measured as described previously (11) . Briefly, after autofluorescence was measured, the tubules were incubated with 30 mol/L Fura-2/AM for 60 min in DMEM under 5% CO 2 /95% O 2 gas at 37°C. Thereafter, the tubule was transferred into the perfusion chamber, microperfused as described above, and [Ca 2ϩ ] i was monitored with the OSP-10 system. The calibration curves were obtained at the end of each experiment, and [Ca 2ϩ ] i were calculated according to the method by Grynkiewicz et al. (21) .
Materials and Statistics
BCECF and Fura-2/AM were obtained from Dojindo, valsartan was from Novartis, 5-ile-AngII, PD 123319, arachidonic acid, (PMA), acetazolamide, and ouabain were from Sigma, and all the other chemicals were from Wako. The data were represented as mean values Ϯ SEM. Significant differences were determined by applying the paired or unpaired t test as appropriate.
Results
The Validity of Stop-Flow Microspectrofluorometric Method
To test whether the stop-flow microspectrofluorometric method, which we have recently developed to measure bicarbonate absorption from rabbit proximal tubules (14, 15) , can also apply to mouse proximal tubules, we performed a series of experiments on isolated proximal tubules from WT. Bicarbonate absorption from proximal tubules has been shown to largely depend on the activities of carbonic anhydrases as well as on the Na ϩ gradient (22) . To test for the role of carbonic anhydrases, we examined the effect of acetazolamide. The addition of acetazolamide (1 mmol/L) to both luminal and basolateral sides for 10 min substantially reduced JHCO 3 Ϫ from 13.0 Ϯ 1.1 to 4.1 Ϯ 0.5 pmol/cm s (68 Ϯ 3% inhibition; n ϭ 6; P Ͻ 0.005). To test for Na ϩ -dependency, we examined the effect of ouabain. The addition of ouabain (1 mmol/L) to the basolateral side for 10 min markedly reduced JHCO 3 Ϫ from 12.3 Ϯ 0.8 to 3.0 Ϯ 0.3 pmol/cm s (76 Ϯ 2% inhibition; n ϭ 7; P Ͻ 0.005). We also tested for Na ϩ -dependency more directly by removing Na ϩ from the ambient solutions. Similarly to all the other experiments, tubules were first perfused for 30 min using Ringer solution and DMEM as the luminal and the basolateral perfusate, respectively. After the control JHCO 3 Ϫ value was obtained, however, both perfusates were switched to Na ϩ -free solution, in which all the Na ϩ in Ringer solution was replaced by N-methely-D-glucamine. The bilateral Na ϩ -removal by this procedure for 10 min also markedly reduced JHCO 3 Ϫ from 11.7
Ϯ 0.9 to 2.4 Ϯ 0.2 pmol/cm s (78 Ϯ 3% inhibition; n ϭ 7; P Ͻ 0.005). In contrast, JHCO 3 Ϫ did not change (n ϭ 5) when Ringer solution, instead of Na ϩ -free solution, was used for the bilateral perfusates, indicating that the reduction in JHCO 3 Ϫ after the Na ϩ -removal was not due to the omission of DMEM. These results are consistent with the characteristics of bicarbonate absorption from proximal tubules (22) , indicating that the stop-flow microspectrofluorometric method can successfully apply to measure bicarbonate absorption from isolated mouse proximal tubules.
Effects of Luminal AngII in WT
To examine the roles of luminal AngII receptors in the regulation of proximal bicarbonate absorption, we first examined the effects of luminal AngII in isolated proximal tubules from WT. As can be seen in Figure 1 , 10-min perfusion with the luminal solution containing 10 Ϫ10 mol/L AngII increased JHCO 3 Ϫ by 42 Ϯ 7% (n ϭ 8; P Ͻ 0.005). On the other hand, 10
Ϫ8 mol/L AngII had no effects (n ϭ 8), and 10 Ϫ6 mol/L AngII rather decreased JHCO 3 Ϫ by 34 Ϯ 4% (n ϭ 7; P Ͻ 0.05). Time control experiments without AngII confirmed that JHCO 3 Ϫ did not change during repeated stop-flow (n ϭ 6). These results indicate that luminal AngII has biphasic effects on JHCO 3 Ϫ in isolated mouse proximal tubules as previously shown in isolated rabbit proximal tubules (12) .
To examine the receptor subtype(s) mediating these AngII effects, we tested an AT 1 antagonist, valsartan. The addition of 2 ϫ 10 Ϫ7 mol/L valsartan into the luminal perfusate did not change JHCO 3 Ϫ (11.8 Ϯ 2.0 versus 12.0 Ϯ 1.9 pmol/cm s; n ϭ 6; NS), but it completely blocked the effects of luminal AngII. Thus, in the presence of valsartan, JHCO 3 Ϫ was not changed by 10 Ϫ10 mol/L AngII (12.8 Ϯ 1.4 versus 12.2 Ϯ 1.5 pmol/cm s; n ϭ 7; NS) and by 10 Ϫ6 mol/L AngII (11.3 Ϯ 1.2 versus 11.3 Ϯ 1.1 pmol/cm s; n ϭ 7; NS). The addition of higher concentrations (2 ϫ 10 Ϫ6 mol/L) of valsartan into the luminal perfusate also did not change JHCO 3 Ϫ (n ϭ 6). To test for a role of AT2, we examine the effects of an AT 2 antagonist PD 123,319. The addition of 10 Ϫ5 mol/L PD 123,319 into the luminal perfusate did not change JHCO 3 Ϫ (11.9 Ϯ 1.8 versus 11.6 Ϯ 2.2 pmol/cm s; n ϭ 6; NS) and did not modify the effects of luminal AngII. Thus, in the presence of PD 123,319, 10 Ϫ10 mol/L AngII increased JHCO 3 Ϫ by 39 Ϯ 8% (n ϭ 7; P Ͻ 0.005), and 10 Ϫ6 mol/L AngII decreased JHCO 3 Ϫ by 32 Ϯ 3% (n ϭ 7, P Ͻ 0.005). These results indicate that the luminal AT 1 mediates both stimulation and inhibition of JHCO 3 Ϫ by AngII. A previous study on isolated rabbit proximal tubules (12) suggested that the presence of physiologic concentrations of AngII in the basolateral side could counteract the inhibition by high concentrations of luminal AngII. We therefore examined the effect of luminal 10 Ϫ6 mol/L AngII in the presence of basolateral 10 Ϫ10 mol/L AngII. The addition of 10 Ϫ10 mol/L AngII to the basolateral side alone for 10 min increased JHCO 3 Ϫ from 10.7 Ϯ 0.7 to 14.1 Ϯ 0.8 pmol/cm s (33 Ϯ 5% stimulation; n ϭ 6; P Ͻ 0.01), as expected. On the other hand, the simultaneous addition of basolateral 10 Ϫ10 mol/L AngII and luminal 10 Ϫ6 mol/L AngII for 10 min significantly reduced JHCO 3 Ϫ from 11.7 Ϯ 0.6 to 7.8 Ϯ 0.5 pmol/cm s (34 Ϯ 2% inhibition; n ϭ 7; P Ͻ 0.005). 
Effects of AngII in AT 1A KO
We next examined the effects of luminal AngII in AT 1A KO. The control JHCO 3 Ϫ in AT 1A KO (11.9 Ϯ 0.8 pmol/cm s; n ϭ 24) was very similar to that in WT (11.7 Ϯ 0.5 pmol/cm s; n ϭ 26). As shown in Figure 2 , the addition of 10 Ϫ10 , 10 Ϫ8 , and 10 Ϫ6 mol/L AngII all failed to change JHCO 3 Ϫ in AT 1A KO. Time control experiments without AngII confirmed that JHCO 3 Ϫ did not change during repeated stop-flow (n ϭ 5). These results are consistent with a view that the biphasic regulation of JHCO 3 Ϫ in WT was mediated by the luminal AT 1A .
Effects of AngII on [Ca 2ϩ ] i
The increase in [Ca 2ϩ ] i could be an important factor in AngII-mediated signaling pathways (8, 9, 23, 24) ; we therefore 
Effects of Arachidonic Acid and PMA on JHCO 3
Ϫ
Previous studies have shown that the activation of phospholipase A 2 (PLA 2 ) and the subsequent release of arachidonic acid could be responsible for the inhibition by high concentrations of AngII (9, 25, 26) . We therefore compared the effects of arachidonic acid on JHCO 3 Ϫ in WT and AT1A KO. As shown in Figure 4 , the addition of 10 Ϫ8 mol/L arachidonic acid to the bath perfusate similarly reduced JHCO 3 Ϫ in WT (Ϫ27 Ϯ 2%; n ϭ 7) and AT 1A KO (Ϫ32 Ϯ 1%; n ϭ 7).
On the other hand, activation of protein kinase C (PKC) could be involved in the stimulation by low concentrations of AngII (24, 27) . Therefore we finally compared the effects of acute PKC activation in WT and AT 1A KO. As shown in Figure 5 , the addition of 5 ϫ 10 Ϫ7 mol/L PMA similarly increased JHCO 3 Ϫ in WT (33 Ϯ 4%; n ϭ 5) and AT 1A KO (36 Ϯ 6%; n ϭ 5).
Discussion
In 1977, Harris and Young (4) reported that AngII added into the peritubular fluid regulates volume absorption from rat proximal tubules in the biphasic way. This finding has been confirmed in various experimental conditions (8, 9, 23, 28, 29) , and other investigators have shown that AngII added into the luminal fluid can also exert the similar biphasic effects (12, 13) . Regarding the signal transduction pathways, the stimulation by AngII is generally thought to be mediated by the activation of PKC and/or the decrease in the level of cAMP in the cell (7, 23, 24, 27) , though a recent study suggests that the activation of tyrosine kinases could be also involved (30) . On the other hand, the activation of PLA 2 and the subsequent release of arachidonic acid seem to be involved in the inhibition by AngII. In particular, a P-450 -dependent arachidonic acid metabolite, 5,6-epoxyeicosatrienoic acid, could be the final mediator of the inhibition by AngII (9, 25, 26) . Although the stimulation by AngII is certainly mediated by AT 1 , conflicting results have been reported as to the receptor subtype responsible for the inhibition by AngII (8, 9, 10) . By comparing the effects of AngII in WT and AT 1A KO, we have recently shown that the biphasic regulation of NBC by AngII is mediated by AT 1A in the basolateral membranes (11) . The study was, however, limited on the basolateral receptors; we could not therefore exclude a possibility that the luminal AT 2 may mediate the inhibition by AngII. To clarify this issue, we compared the effects of luminal AngII in WT and AT 1A KO in the present study. To measure bicarbonate absorption, we used the stopflow microspectrofluorometric method, which we have recently developed for isolated rabbit proximal tubules (14, 15) . The validity of this method was confirmed by series of experiments with acetazolamide, ouabain, and Na ϩ -free solution on isolated proximal tubules from WT, which reproduced the previously characterized properties of proximal bicarbonate transport (22) .
In WT, the biphasic regulation of JHCO 3 Ϫ by AngII was completely inhibited by the highly selective AT 1 antagonist, valsartan (31) . However, the AT 2 antagonist PD 123,319 did not modify the effects of AngII. In AT 1A KO, the effects of luminal AngII on JHCO 3 Ϫ were completely lost. On the other hand, the stimulation by PMA as well as the inhibition by arachidonic acid was very similar in WT and AT 1A KO, indicating that the stimulatory and inhibitory signaling pathways required for AngII actions are intact in AT 1A KO as we previously reported (11) . These results are consistent with a view that the luminal AT 1A mediates the biphasic regulation of bicarbonate absorption from proximal tubules.
Because of remarkably high proximal intratubular concentrations of AngII and the presence of angiotensinogen and its mRNA in proximal tubules, AngII is thought be directly secreted into proximal tubular lumen by the epithelial cells (13). Baum et al. (32) reported that this endogenously secreted AngII was able to modify bicarbonate absorption from isolated proximal tubules. In the present study, however, the addition of sufficient concentrations of valsartan did not change JHCO 3 Ϫ in WT, which did not support a role of endogenous AngII. One possible explanation for these apparently conflicting results could be that we used the very high luminal perfusion rates (Ͼ80 nl/min) to perform stop-flow measurements, whereas Baum et al. (32) used the much lower (approximately 10 nl/min) perfusion rates to measure JHCO 3 Ϫ by the conventional picapnotherm method. On the other hand, a previous study on isolated rabbit proximal tubules (12) provided data suggesting that the inhibition by high concentration of luminal AngII could be blunted by the presence of physiologic concentrations of basolateral AngII. In contrast, we showed that the inhibition by 10 Ϫ6 mol/L luminal AngII in WT was preserved even in the presence of basolateral 10 Ϫ10 mol/L AngII. The reason for these discrepant results is not apparent, but species difference could be involved.
In the previous study, we observed that 10 Ϫ6 mol/L basolateral AngII slightly stimulated the NBC activity in AT 1A KO, which was completely inhibited by valsartan (11) . In the present study, however, 10 Ϫ6 mol/L luminal AngII had no effects on JHCO 3 Ϫ in AT 1A KO. The pharmacologic properties of AT 1A and AT 1B are known to be very similar (1,2) ; therefore, the most likely explanation for these observations would be that AT 1B is expressed at a low level in the basolateral membranes but not in the apical membranes of proximal tubules. A previous study has confirmed the low-level expression of AT 1B in proximal tubules (33) , but whether it is expressed in the basolateral or the apical membranes has not been determined. The future studies on AT 1B -deficient mice would help clarify this issue.
When high concentrations of AngII were added into the luminal fluid, some of the peptide could diffuse out of the lumen through the paracellular pathways and might act also on the basolateral receptors. However, the [ ] i in isolated mouse proximal tubules. At present the reason for these discrepant results is unknown, but the difference in metabolic status of isolated tubules could be responsible.
Taken together with the results of our previous study about the NBC regulation by AngII (11), we can now conclude that AT 1A , whether expressed in the basolateral or the apical membranes, mediates the biphasic regulation of proximal transport. In contrast to our conclusion, Haithcock et al. (10) , using cultured proximal tubular cells, presented the evidence that AT 2 mediates the inhibition by high concentrations of AngII. Other studies on cultured proximal tubular cells also suggested a role of AT 2 in the acute inhibitory effect of AngII (35, 36) . While the reason for the discrepant results is not apparent, it has been shown that the expression of AT 2 in kidney is very high in the developing fetus but declines soon after birth (37, 38) . It could be possible that cultured proximal tubular cells, depending on the culture conditions, might express a significant amount of AT 2 . On the other hand, we cannot exclude a possibility that AT 2 may play some physiologic roles in adult kidney. For example, AngII has been shown to activate NF-B in proximal tubules through both AT 1 and AT 2 (39) , and AT 2 could mediate long-term effects of AngII in vivo through such a mechanism. Nevertheless, the results from our studies on isolated proximal tubules strongly argue against a significant role of AT 2 in the acute regulation of proximal transport by AngII.
